Related references
Note: Only part of the references are listed.New approaches for targeting platinum-resistant ovarian cancer
Michelle McMullen et al.
SEMINARS IN CANCER BIOLOGY (2021)
New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells
Mariafrancesca Hyeraci et al.
CHEMMEDCHEM (2021)
Cytotoxicity and DNA interaction in a series of aryl terminated iminopyridine Pt(II) complexes
Riccardo Bondi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2021)
Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies
Qing Tang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents
Neife Aparecida Guinaim dos Santos et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Platinum(II) Complexes Bearing Triphenylphosphine and Chelating Oximes: Antiproliferative Effect and Biological Profile in Resistant Cells
Mariafrancesca Hyeraci et al.
CHEMMEDCHEM (2020)
High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis
Hongyu Cai et al.
ONCOLOGY LETTERS (2020)
Role of Nucleotide Excision Repair in Cisplatin Resistance
Mingrui Duan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Implications of Topoisomerase (TOP1 and TOP2α) Expression in Patients With Breast Cancer
Misato Ogino et al.
IN VIVO (2020)
TOP2A Promotes Tumorigenesis of High-grade Serous Ovarian Cancer by Regulating the TGF-β/Smad Pathway
Yan Gao et al.
JOURNAL OF CANCER (2020)
Cisplatin nephrotoxicity: a review of the literature
Sandhya Manohar et al.
JOURNAL OF NEPHROLOGY (2018)
Synthesis and Reactivity of Cytotoxic Platinum(II) Complexes of Bidentate Oximes - A Step towards the Functionalization of Bioactive Complexes
Daniela Belli Dell'Amico et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2018)
Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer
Hideo Shigematsu et al.
Oncotarget (2018)
Biological evaluation of organometallic palladium(II) complexes containing 4-hydroxybenzoic acid (3-ethoxy-2-hydroxybenzylidene)hydrazide: Synthesis, structure, DNA/protein binding, antioxidant activity and cytotoxicity
Ganesan Ayyannan et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2017)
Biomolecular interaction and cytotoxicity of ruthenium(III) benzothiazole substituted ferrocenyl thiosemicarbazone complexes
K. Sampath et al.
ARABIAN JOURNAL OF CHEMISTRY (2017)
New trans dichloro (triphenylphosphine)platinum(II) complexes containing N-(butyl),N-(arylmethyl)amino ligands: Synthesis, cytotoxicity and mechanism of action
Lisa Dalla Via et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Role of transporters in the distribution of platinum-based drugs
Saliha Harrach et al.
FRONTIERS IN PHARMACOLOGY (2015)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: Synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities
Govindan Prakash et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2014)
TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma
Jui Lan et al.
TUMOR BIOLOGY (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
New organometallic ruthenium(II) complexes containing chelidonic acid (4-oxo-4H-pyran-2,6-dicarboxylic acid): synthesis, structure and in vitro biological activity
Thangavel Sathiya Kamatchi et al.
RSC ADVANCES (2014)
Synthesis, antiproliferative and mitochondrial impairment activities of bis-alkyl-amino transplatinum complexes
Lisa Dalla Via et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Cellular and molecular mechanisms of mitochondrial function
Laura D. Osellame et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A convenient route to dinuclear chloro-bridged platinum(II) derivatives via nitrile complexes
Daniela Belli Dell'Amico et al.
DALTON TRANSACTIONS (2012)
Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: Impact of oxidation state and co-ligands on anticancer activity in vitro
Thangavel Sathiya Kamatchi et al.
DALTON TRANSACTIONS (2012)
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding-Wu Shen et al.
PHARMACOLOGICAL REVIEWS (2012)
Platinum(II) chloride indenyl complexes: electrochemical and biological evaluation
Lisa Dalla Via et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
Synthesis, characterization and tumor cell growth inhibition of new trans platinum complexes with phosphane derivatives
A. G. Quiroga et al.
POLYHEDRON (2011)
DNA topoisomerase II and its growing repertoire of biological functions
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
G. Ferrandina et al.
BRITISH JOURNAL OF CANCER (2008)
The CellScan technology for in vitro studies on novel platinum complexes with organoarsenic ligands
Eva Fischer-Fodor et al.
DALTON TRANSACTIONS (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin
Francisco J. Ramos-Lima et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The trans effect and trans influence of triphenyl arsine in platinum(II) complexes. A comparative mechanistic and structural study
N Kuznik et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2002)